David Tanen is a co-founder and Corporate Secretary of IconOVir Bio. David is also a co-founder and Partner of Two River, which focuses on creating, operating and financing development stage life science companies. David was also a co-founder of Kite Pharma, Inc., where he served as Corporate Secretary and General Counsel until its acquisition by Gilead Sciences in 2017. He is a co-founder and director of Kronos Bio, Inc. (KRON), a co-founder, director, and Corporate Secretary of Neogene Therapeutics, Inc. and a co-founder and Corporate Secretary of Allogene Therapeutics, Inc. (ALLO). David also serves as an Advisor to Vida Ventures, LLC.
He received his B.A. from The George Washington University and his J.D. from Fordham University School of Law, where he has served on the Dean’s Planning Council since 2009.